Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

bavarian nordic a/s - BVNRY

BVNRY

Close Chg Chg %
7.55 0.08 1.03%

Closed Market

7.63

+0.08 (1.03%)

Volume: 755.00

Last Updated:

Mar 28, 2025, 1:50 PM EDT

Trade Now

Company Overview: bavarian nordic a/s - BVNRY

BVNRY Key Data

Open

$7.60

 Day Range

7.60 - 7.63

52 Week Range

6.86 - 14.60

 Market Cap

$1.79B

Shares Outstanding

235.65M

 Public Float

N/A

Beta

2.02

 Rev. Per Employee

N/A

P/E Ratio

12.36

 EPS

$0.60

Yield

0.00%

 Dividend

$0.54

EX-DIVIDEND DATE

Mar 27, 2020

 SHORT INTEREST

N/A

AVERAGE VOLUME

11.53K

  

BVNRY Performance

1 Week
 
 -3.73%
 
1 Month
 
 -1.17%
 
3 Months
 
 -14.75%
 
1 Year
 
 2.69%
 
5 Years
 
 N/A
 

BVNRY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About bavarian nordic a/s - BVNRY

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

BVNRY At a Glance

Bavarian Nordic A/S
Philip Heymans Alle 3
Hellerup, Capital Region 2900
Phone 45-33-26-83-83 Revenue 828.18M
Industry Pharmaceuticals: Major Net Income 143.28M
Sector Health Technology Employees 1,611
Fiscal Year-end 12 / 2025
View SEC Filings

BVNRY Valuation

P/E Current 12.357
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 14.332
Price to Sales Ratio 2.48
Price to Book Ratio 1.304
Price to Cash Flow Ratio 7.262
Enterprise Value to EBITDA 7.825
Enterprise Value to Sales 2.136
Total Debt to Enterprise Value 0.01

BVNRY Efficiency

Revenue/Employee 514,080.401
Income Per Employee 88,937.929
Receivables Turnover 4.887
Total Asset Turnover 0.401

BVNRY Liquidity

Current Ratio 2.069
Quick Ratio 1.237
Cash Ratio 0.778

BVNRY Profitability

Gross Margin 47.88
Operating Margin 16.36
Pretax Margin 17.009
Net Margin 17.30
Return on Assets 6.943
Return on Equity 9.195
Return on Total Capital 8.944
Return on Invested Capital 9.117

BVNRY Capital Structure

Total Debt to Total Equity 1.124
Total Debt to Total Capital 1.112
Total Debt to Total Assets 0.89
Long-Term Debt to Equity 0.76
Long-Term Debt to Total Capital 0.752
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Bavarian Nordic A/s - BVNRY

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
300.51M 445.12M 1.02B 828.18M
Sales Growth
+6.84% +48.12% +130.05% -19.12%
Cost of Goods Sold (COGS) incl D&A
217.16M 211.37M 367.90M 431.65M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
61.62M 56.40M 80.36M 90.62M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
+17.20% -2.67% +74.05% +17.33%
Gross Income
83.35M 233.74M 656.09M 396.53M
Gross Income Growth
-13.16% +180.45% +180.69% -39.56%
Gross Profit Margin
+27.73% +52.51% +64.07% +47.88%
2021 2022 2023 2024 5-year trend
SG&A Expense
134.20M 243.74M 438.81M 261.04M
Research & Development
62.69M 166.23M 320.44M 122.12M
Other SG&A
71.52M 77.51M 118.37M 138.92M
SGA Growth
+10.01% +81.62% +80.03% -40.51%
Other Operating Expense
- - - -
-
Unusual Expense
21.30M 36.27M 5.99M 9.64M
EBIT after Unusual Expense
(72.15M) (46.27M) 211.30M 125.85M
Non Operating Income/Expense
2.87M 1.77M 6.05M 17.02M
Non-Operating Interest Income
2.03M 2.76M 7.92M 7.01M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
2.94M 2.35M 2.18M 2.00M
Interest Expense Growth
-39.68% -19.99% -7.25% -8.17%
Gross Interest Expense
2.94M 2.35M 2.18M 2.00M
Interest Capitalized
- - - -
-
Pretax Income
(72.22M) (46.85M) 215.17M 140.87M
Pretax Income Growth
-267.49% +35.14% +559.30% -34.53%
Pretax Margin
-24.03% -10.52% +21.01% +17.01%
Income Tax
1.64M 2.23M 1.13M (2.41M)
Income Tax - Current - Domestic
1.64M 2.23M 226.93K 1.17M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - 898.15K (3.58M)
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(73.87M) (49.07M) 214.05M 143.28M
Minority Interest Expense
- - - -
-
Net Income
(73.87M) (49.07M) 214.05M 143.28M
Net Income Growth
-274.06% +33.56% +536.16% -33.06%
Net Margin Growth
-24.58% -11.03% +20.90% +17.30%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(73.87M) (49.07M) 214.05M 143.28M
Preferred Dividends
- - - -
-
Net Income Available to Common
(73.87M) (49.07M) 214.05M 143.28M
EPS (Basic)
-0.3902 -0.2323 0.9301 0.6115
EPS (Basic) Growth
-249.10% +40.47% +500.39% -34.25%
Basic Shares Outstanding
189.31M 211.26M 230.13M 234.31M
EPS (Diluted)
-0.3902 -0.2323 0.9301 0.6115
EPS (Diluted) Growth
-249.10% +40.47% +500.39% -34.25%
Diluted Shares Outstanding
189.31M 211.26M 230.13M 234.31M
EBITDA
10.76M 46.40M 297.64M 226.12M
EBITDA Growth
-59.55% +331.31% +541.44% -24.03%
EBITDA Margin
+3.58% +10.42% +29.07% +27.30%

Bavarian Nordic A/S in the News